Genomics

Dataset Information

0

Malignant A-to-I RNA editing by ADAR1 drives T-cell acute lymphoblastic leukemia relapse via attenuating dsRNA sensing


ABSTRACT: Leukemia initiating cells (LICs) are regarded as the origin of leukemia relapse and therapeutic resistance. Identifying direct stemness determinants that fuel LIC self-renewal is critical for developing targeted approaches to eliminate LICs and prevent relapse. Here, we show that the RNA editing enzyme ADAR1 is a crucial stemness factor that promotes LIC self-renewal by attenuating aberrant double-stranded RNA (dsRNA) sensing. Elevated adenosine-to-inosine (A-to-I) editing is a common attribute of relapsed T-ALL regardless of molecular subtypes. Consequently, knockdown of ADAR1 severely inhibits LIC self-renewal capacity and prolongs survival in T-ALL PDX models. Mechanistically, ADAR1 directs hyper-editing of immunogenic dsRNA to avoid detection by the innate immune sensor MDA5. Moreover, we uncovered that the cell intrinsic level of MDA5 dictates the dependency on ADAR1-MDA5 axis in T-ALL. Collectively, our results show that ADAR1 functions as a self-renewal factor that limits the sensing of endogenous dsRNA. Thus, targeting ADAR1 presents an effective therapeutic strategy for eliminating T-ALL LICs.

ORGANISM(S): Homo sapiens

PROVIDER: GSE221112 | GEO | 2023/12/31

REPOSITORIES: GEO

Similar Datasets

2023-10-03 | GSE198386 | GEO
2017-08-14 | GSE94386 | GEO
2017-08-14 | GSE94388 | GEO
2017-08-14 | GSE94387 | GEO
2022-03-24 | GSE147861 | GEO
2022-03-24 | GSE147860 | GEO
2022-03-24 | GSE147859 | GEO
2022-03-24 | GSE179733 | GEO
2022-03-24 | GSE179732 | GEO
2022-08-24 | PXD024974 | Pride